Related Experiment Video

Updated: Jul 17, 2026

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
07:08

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Published on: February 2, 2024

Current controversies in the management of pancreatic cancer

Robert A Wolff1

  • 1GI Medical Oncology, The University of Texas, M D Anderson Cancer Center, Houston, TX, USA.

Clinical Advances in Hematology & Oncology : H&O
|January 20, 2007
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Management of the Uncinate Process in No-Touch Laparoscopic Pancreaticoduodenectomy
09:32

Management of the Uncinate Process in No-Touch Laparoscopic Pancreaticoduodenectomy

Published on: May 5, 2023

Related Experiment Videos

Last Updated: Jul 17, 2026

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
07:08

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Published on: February 2, 2024

Management of the Uncinate Process in No-Touch Laparoscopic Pancreaticoduodenectomy
09:32

Management of the Uncinate Process in No-Touch Laparoscopic Pancreaticoduodenectomy

Published on: May 5, 2023

Related Concept Videos

Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...

Articles linked to this work by shared authors, journal, and citation graph.

Clinical impact of prospective circulating tumour DNA testing for minimal residual disease in colorectal cancer: the INTERCEPT programme experience.

Gut·2026

Overall survival of immunotherapy versus standard of care in chemorefractory microsatellite stable metastatic colorectal cancer: a propensity score matched analysis of 708 patients.

Journal for immunotherapy of cancer·2026

Clinical and translational results from a phase 1 trial of gemcitabine/nab-paclitaxel with nivolumab/ipilimumab or hydroxychloroquine/ipilimumab in untreated metastatic pancreatic adenocarcinoma.

Journal for immunotherapy of cancer·2026

Clinicopathologic Characteristics of Brain Metastasis of Pancreatic Ductal Adenocarcinoma.

The American journal of surgical pathology·2025

Phase 1/2 trial of encorafenib, cetuximab, and nivolumab in microsatellite stable BRAFV600E metastatic colorectal cancer.

Cancer cell·2025

A spatial atlas of chemoradiation therapy in pancreatic cancer identifies cellular and microenvironmental determinants of persister populations.

bioRxiv : the preprint server for biology·2025

Redefining second-line treatment strategy, sequencing, and real-world implementation in relapsed/refractory multiple myeloma: insights from the 31st Annual Congress of the European Hematology Association.

Clinical advances in hematology & oncology : H&O·2026

Neoadjuvant therapies in high-risk localized prostate cancer: past, present, and future.

Clinical advances in hematology & oncology : H&O·2026

Artificial intelligence in prostate cancer diagnosis and management: state-of-the-art approaches and emerging innovations.

Clinical advances in hematology & oncology : H&O·2026

Clinical applications of PARP inhibitors in breast, ovarian, and prostate cancer: current insights and future directions.

Clinical advances in hematology & oncology : H&O·2026

C2ORF68 stabilizes SIVA1 to upregulate BCL-2 and suppress apoptosis in gallbladder cancer.

Cell death discovery·2026

Circular RNAs in Breast Cancer Immunometabolism: Mechanisms of Immune Regulation and Metabolic Reprogramming.

Critical reviews in oncology/hematology·2026

Cell cycle arrest of a craniofacial epithelial population shapes faces in mice and humans.

Developmental cell·2026

Berberine increases the sensitivity of sorafenib in human hepatocellular carcinoma via inducing HIF-1α-mediated energy crisis.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2026

Imperatorin exerts anti-colorectal cancer effects by targeting NOX2 to inhibit mast cell degranulation.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2026

The gut-pancreas axis in chronic pancreatitis: Microbiota-endogenous GLP-1 interactions and candidate repair pathways.

Microbiological research·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us